• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌死亡率与发病率之比与 35 个国家的癌症护理差距有关。

Prostate Cancer Mortality-To-Incidence Ratios Are Associated with Cancer Care Disparities in 35 Countries.

机构信息

Department of Urology, Chung Shan Medical University Hospital, Taichung, Taiwan.

School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

出版信息

Sci Rep. 2017 Jan 4;7:40003. doi: 10.1038/srep40003.

DOI:10.1038/srep40003
PMID:28051150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5209738/
Abstract

The variation in mortality-to-incidence ratios (MIRs) among countries reflects the clinical outcomes and the available interventions for colorectal cancer treatments. The association between MIR of prostate cancer and cancer care disparities among countries is an interesting issue that is rarely investigated. For the present study, cancer incidence and mortality rates were obtained from the GLOBOCAN 2012 database. The rankings and total expenditures on health of various countries were obtained from the World Health Organization (WHO). The association between variables was analyzed by linear regression analyses. In this study, we estimated the role of MIRs from 35 countries that had a prostate cancer incidence greater than 5,000 cases per year. As expected, high prostate cancer incidence and mortality rates were observed in more developed regions, such as Europe and the Americas. However, the MIRs were 2.5 times higher in the less developed regions. Regarding the association between MIR and cancer care disparities, countries with good WHO ranking and high total expenditures on health/gross domestic product (GDP) were significant correlated with low MIR. The MIR variation for prostate cancer correlates with cancer care disparities among countries further support the role of cancer care disparities in clinical outcome.

摘要

各国之间死亡率与发病率比(MIR)的差异反映了结直肠癌治疗的临床结果和可获得的干预措施。前列腺癌的 MIR 与各国之间癌症护理差异之间的关联是一个很少被研究的有趣问题。在本研究中,癌症发病率和死亡率数据来自 GLOBOCAN 2012 数据库。各国的排名和卫生总支出数据来自世界卫生组织(WHO)。通过线性回归分析研究变量之间的关联。在这项研究中,我们估计了来自 35 个每年前列腺癌发病率超过 5000 例的国家的 MIR 作用。正如预期的那样,在欧洲和美洲等较发达地区,观察到较高的前列腺癌发病率和死亡率。然而,在欠发达地区,MIR 要高出 2.5 倍。关于 MIR 与癌症护理差异之间的关联,在 WHO 排名较好和卫生总支出/国内生产总值(GDP)较高的国家,与低 MIR 显著相关。前列腺癌的 MIR 变化与各国之间的癌症护理差异进一步支持了癌症护理差异在临床结果中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f5/5209738/11af6f0d6adf/srep40003-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f5/5209738/f0ce1bed36b9/srep40003-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f5/5209738/11af6f0d6adf/srep40003-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f5/5209738/f0ce1bed36b9/srep40003-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f5/5209738/11af6f0d6adf/srep40003-f2.jpg

相似文献

1
Prostate Cancer Mortality-To-Incidence Ratios Are Associated with Cancer Care Disparities in 35 Countries.前列腺癌死亡率与发病率之比与 35 个国家的癌症护理差距有关。
Sci Rep. 2017 Jan 4;7:40003. doi: 10.1038/srep40003.
2
Unfavorable Mortality-To-Incidence Ratio of Lung Cancer Is Associated with Health Care Disparity.肺癌病死率与发病比的不利关系与医疗保健差异有关。
Int J Environ Res Public Health. 2018 Dec 17;15(12):2889. doi: 10.3390/ijerph15122889.
3
Health disparities are associated with gastric cancer mortality-to-incidence ratios in 57 countries.卫生差异与 57 个国家的胃癌死亡率与发病率比有关。
World J Gastroenterol. 2017 Nov 28;23(44):7881-7887. doi: 10.3748/wjg.v23.i44.7881.
4
Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries.胰腺癌的死亡率与发病率之比是否与健康差异相关?一项对57个国家的横断面数据库分析。
BMJ Open. 2018 Jul 6;8(7):e020618. doi: 10.1136/bmjopen-2017-020618.
5
Favorable cervical cancer mortality-to-incidence ratios of countries with good human development index rankings and high health expenditures.在人类发展指数排名较好且卫生支出较高的国家,宫颈癌死亡率与发病率之比有利。
BMC Womens Health. 2023 May 25;23(1):284. doi: 10.1186/s12905-023-02423-y.
6
The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: National estimates from 33 countries.性别差异和病死率与发病率比值与膀胱癌的医疗保健差异有关:来自 33 个国家的全国估计数。
Sci Rep. 2017 Jun 28;7(1):4360. doi: 10.1038/s41598-017-04083-z.
7
Correlations between Mortality-to-Incidence Ratios and Health Care Disparities in Testicular Cancer.死亡率与发病率比值与睾丸癌医疗保健差异的相关性。
Int J Environ Res Public Health. 2019 Dec 23;17(1):130. doi: 10.3390/ijerph17010130.
8
Favorable gallbladder cancer mortality-to-incidence ratios of countries with good ranking of world's health system and high expenditures on health.胆囊癌死亡率与发病率比值有利的国家,其世界卫生系统排名较好,且在卫生保健方面支出较高。
BMC Public Health. 2019 Jul 31;19(1):1025. doi: 10.1186/s12889-019-7160-z.
9
Favorable breast cancer mortality-to-incidence ratios of countries with good human development index rankings and high health expenditures.在人类发展指数排名较高和卫生支出较高的国家,乳腺癌死亡率与发病率的比值有利。
Taiwan J Obstet Gynecol. 2024 Jul;63(4):527-531. doi: 10.1016/j.tjog.2023.11.012.
10
Favorable mortality-to-incidence ratios of kidney Cancer are associated with advanced health care systems.肾癌的死亡率与发病率比值有利,与先进的医疗保健系统有关。
BMC Cancer. 2018 Aug 6;18(1):792. doi: 10.1186/s12885-018-4698-6.

引用本文的文献

1
The burden of thyroid cancer and its association with national development levels in Asia: evidence from 47 countries (1990-2021).亚洲甲状腺癌负担及其与国家发展水平的关联:来自47个国家的证据(1990 - 2021年)
Front Oncol. 2025 Aug 13;15:1632221. doi: 10.3389/fonc.2025.1632221. eCollection 2025.
2
The Association of and Expression Profile in Patients with Prostate Cancer History.有前列腺癌病史患者中[具体内容缺失]与[具体内容缺失]表达谱的关联
Adv Biomed Res. 2025 Jul 21;14:65. doi: 10.4103/abr.abr_419_24. eCollection 2025.
3
Occupational Benzene Exposure and Risk of Male Genital Cancers: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?德国和美国前列腺癌生存率比较:差异能否归因于分期分布的不同?
BJU Int. 2017 Apr;119(4):550-559. doi: 10.1111/bju.13537. Epub 2016 Jun 20.
2
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.50 - 54岁开始的前列腺癌筛查。一项基于人群的队列研究。
Eur Urol. 2017 Jan;71(1):46-52. doi: 10.1016/j.eururo.2016.03.026. Epub 2016 Apr 13.
3
Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies.
职业性苯暴露与男性生殖系统癌症风险:一项系统评价与荟萃分析。
Am J Ind Med. 2025 Aug;68(8):666-678. doi: 10.1002/ajim.23740. Epub 2025 May 27.
4
Analyzing the cancer mortality-to-incidence ratios and health expenditures in the aging population: a 20-year comparative study across high-income countries.分析老年人口中的癌症死亡率与发病率之比及医疗支出:一项对高收入国家进行的为期20年的比较研究。
Front Aging. 2025 Jan 22;6:1506897. doi: 10.3389/fragi.2025.1506897. eCollection 2025.
5
Correlation Between CT Density, Incidence, Mortality, and Mortality-to-Incidence Ratio in Central Nervous System Cancers: An Exploratory Analysis of Global Data.中枢神经系统癌症中 CT 密度、发病率、死亡率和死亡率与发病率比的相关性:全球数据的探索性分析。
In Vivo. 2024 Jul-Aug;38(4):2024-2030. doi: 10.21873/invivo.13660.
6
The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden.诊断后生命年损失率(FLYLAD):一种以患者为中心的癌症负担衡量指标。
Popul Health Metr. 2023 Sep 13;21(1):14. doi: 10.1186/s12963-023-00314-w.
7
Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020.基于2020年全球癌症负担估计数据,白血病治疗结果中的性别差异与医疗保健支出的关系。
Arch Public Health. 2023 Aug 21;81(1):151. doi: 10.1186/s13690-023-01154-8.
8
Editorial Comment.编者按。
Indian J Urol. 2023 Apr-Jun;39(2):155-156. doi: 10.4103/iju.iju_101_23. Epub 2023 Mar 31.
9
Favorable cervical cancer mortality-to-incidence ratios of countries with good human development index rankings and high health expenditures.在人类发展指数排名较好且卫生支出较高的国家,宫颈癌死亡率与发病率之比有利。
BMC Womens Health. 2023 May 25;23(1):284. doi: 10.1186/s12905-023-02423-y.
10
Patterns of better breast cancer care in countries with higher human development index and healthcare expenditure: Insights from GLOBOCAN 2020.高人类发展指数和高医疗支出国家中更好的乳腺癌护理模式:来自 GLOBOCAN 2020 的洞察。
Front Public Health. 2023 Apr 12;11:1137286. doi: 10.3389/fpubh.2023.1137286. eCollection 2023.
前列腺特异性抗原筛查和选择性治疗策略的经济分析。
JAMA Oncol. 2016 Jul 1;2(7):890-8. doi: 10.1001/jamaoncol.2015.6275.
4
Prostate cancer in men of African origin.男性非洲裔人群的前列腺癌。
Nat Rev Urol. 2016 Feb;13(2):99-107. doi: 10.1038/nrurol.2015.298. Epub 2015 Dec 31.
5
Prostate Cancer Claims for a Personalized Medicine.前列腺癌对个性化医疗的需求
N Am J Med Sci. 2015 Oct;7(10):436-7. doi: 10.4103/1947-2714.168661.
6
The Global Burden of Cancer 2013.《2013 年全球癌症负担》。
JAMA Oncol. 2015 Jul;1(4):505-27. doi: 10.1001/jamaoncol.2015.0735.
7
Prostate cancer.前列腺癌。
Lancet. 2016 Jan 2;387(10013):70-82. doi: 10.1016/S0140-6736(14)61947-4. Epub 2015 Jun 11.
8
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.晚期前列腺癌患者的管理:2015年圣加仑晚期前列腺癌共识会议(APCCC)的建议
Ann Oncol. 2015 Aug;26(8):1589-604. doi: 10.1093/annonc/mdv257. Epub 2015 Jun 3.
9
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
10
Changes in prognostic and therapeutic parameters in prostate cancer from an epidemiological view over 20 years.20 年来从流行病学角度看前列腺癌预后和治疗参数的变化。
Oncol Res Treat. 2015;38(1-2):8-14. doi: 10.1159/000371717. Epub 2015 Jan 26.